eFFECTOR Therapeutics doses first patient in Ph2b kickstart clinical trial

Clinical Impact

Jun 9

Written By Frances Benson

https://investors.effector.com/news-releases/news-release-details/effector-therapeutics-doses-first-patient-phase-2b-kickstart

2021

Frances Benson

CRISPR Therapeutics and Capsida Biotherapeutics announce strategic collaboration

eFFECTOR Therapeutics and Locust Walk Acquisition Corp Annouce Merger